Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study in Patients Previously Treated With Mustang Bio, Inc. CAR-T Cell Investigational Products

NCT05645744 is registered in ClinicalTrials.gov with Mustang Bio as lead sponsor.

NCT NCT05645744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05645744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study in Patients Previously Treated With Mustang Bio, Inc. CAR-T Cell Investigational Products
Lead sponsor
Mustang Bio
Phase
Observational
Overall status
Terminated
Start date
September 29, 2021
Completion date
April 12, 2024
Enrollment
3 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphoma refractory, blastic plasmacytoid dendritic cell neoplasm (bpdcn), chronic lymphocytic leukemia in relapse, diffuse large b cell lymphoma, follicular b-cell non-hodgkin's lymphoma, hairy cell leukemia, mantle cell lymphoma recurrent, mantle cell lymphoma refractory, small lymphocytic lymphoma, relapsed, waldenstrom's macroglobulinemia recurrent, waldenstrom's macroglobulinemia refractory